ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Rhode Island » Internal Medicine

Top Internal Medicine Prescribers in Rhode Island

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
TIMOTHY MANOWN M.D.

Internal Medicine

9,256

$352K

433
376 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 22%

$38
Average prescription price

Avg: $51

YUL EJNES MD

Internal Medicine

8,376

$350K

395
341 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $51

JADRANKA STIPICH MD

Internal Medicine

4,964

$348K

222
198 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 22%

$70
Average prescription price

Avg: $51

MITCHELL PRESSMAN MD

Internal Medicine

8,176

$342K

385
348 are 65+

N/A

8%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $51

ANTHONY LOMBARDI M.D.

Internal Medicine

6,726

$330K

272
238 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $51

GEOFFREY BERG MD

Internal Medicine

8,442

$330K

393
319 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$39
Average prescription price

Avg: $51

RAJEEV GUPTA M.D.

Internal Medicine

6,576

$323K

260
218 are 65+

N/A

12%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $51

RICHARD TURNER MD

Internal Medicine

5,925

$317K

235
223 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $51

IWONA PAOLUCCI M.D.

Internal Medicine

6,210

$282K

277
248 are 65+

N/A

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $51

JAMES GOSPER MD

Internal Medicine

6,893

$278K

290
246 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $51

HAROLDO MELO MD

Internal Medicine

3,925

$273K

200
119 are 65+

N/A

13%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$69
Average prescription price

Avg: $51

KATHLEEN HENDERSON M.D.

Internal Medicine

5,812

$257K

273
243 are 65+

N/A

5%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $51

FRANK SAVORETTI MD

Internal Medicine

7,794

$248K

490
435 are 65+

N/A

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 22%

$32
Average prescription price

Avg: $51

MONIQUE POULIOT D.O.

Internal Medicine

5,356

$245K

234
200 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $51

DANIEL ASIEDU MD

Internal Medicine

4,105

$239K

182
140 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $51

USHA PANNEERSELVAM MD

Internal Medicine

5,756

$231K

216
190 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $51

OMAR MEER M.D.

Internal Medicine

5,612

$224K

219
148 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

21%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $51

JAVID CALCATTI MD

Internal Medicine

6,034

$224K

264
219 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $51

MANISH DESAI M.D.

Internal Medicine

3,226

$217K

117
17 are 65+

N/A
N/A

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$67
Average prescription price

Avg: $51

SHAHID KHAN MD

Internal Medicine

4,134

$204K

235
196 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $51

RIKHI D'SOUZA DO

Internal Medicine

3,804

$201K

246
183 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $51

HOWARD SCHULMAN MD

Internal Medicine

4,724

$197K

427
333 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $51

JEANNE OLIVA MD

Internal Medicine

5,022

$188K

304
266 are 65+

N/A

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $51

MICHAEL MARTIN D.O.

Internal Medicine

4,568

$187K

266
230 are 65+

N/A

9%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$41
Average prescription price

Avg: $51

LYNN SOMMERVILLE MD

Internal Medicine

3,675

$187K

192
169 are 65+

N/A
N/A

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $51

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank